Collage photo of Shaalan Beg and David Wang
Feb 11, 2025, 08:51
Recap of key studies from GI25 – ASCO
American Society of Clinical Oncology (ASCO) shared a post on X:
“Shaalan Beg and David Wang recap key studies from GI25 and highlight research on CRC, esophageal cancer, ctDNA and more on the latest episode of the ASCO Daily News Podcast.”
Shaalan Beg, Senior Advisor for Clinical Research at National Cancer Institute, shared this post, adding:
“Update on this:
Breakwater trial shows significant survival advantage to targeted therapy for BRAF mutated colorectal cancer.”
More posts featuring ASCO and Shaalan Beg.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 12, 2025, 10:40
Mar 12, 2025, 10:36
Mar 12, 2025, 10:29
Mar 12, 2025, 10:16
Mar 12, 2025, 09:59